Knowledge Center

Poster / Nov 13, 2016

Aerodynamic Performance of DPIs versus Process Efficiency

Authors:
  • Filipa Maia
  • Maria Palha
  • Isabel Lopes
  • Filipe Neves
Source:
AAPS 2016

Dry powder inhalers target optimal performance, but should also consider the robustness of the downstream processes. Blend compositions which improve Fine Particle Fraction (FPF5μ³¾/·¡¶Ù) hinder process yield (rejection rate, RR) and device performance (emitted dose, ED). This work establishes relationships between blend rheology, product performance and downstream process efficiency and sets a Design Space which integrates different trade-offs between Product and Process optimization.

Related links

Also in the Knowledge Center

Related Content

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Analytical Support

ËÄÉ«AV has experience and capabilities to provide analytical services for Drug Substance, Drug Product and Inhalation Drug Product at all stages of development and commercial phases.

Page
Read more

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page
Read more